Navigation Links
PROLOR Biotech To Present Preclinical Data On Its Long-Acting Clotting Factor Vlla At 2012 ASH Annual Meeting
Date:12/7/2012

Investors are cautioned that forward-looking statements involve risks and uncertainties that may affect PROLOR's business and prospects, including the risks that PROLOR may not succeed in generating any revenues or developing any commercial products, including any long-acting versions of human growth hormone, erythropoietin, interferon beta, GLP-1 and other products; that the long-acting products in development may fail, may not achieve the expected results or effectiveness and/or may not generate data that would support the approval or marketing of these products for the indications being studied or for other indications; that ongoing studies may not continue to show substantial or any activity; that the actual dollar amount of any grants from Israel's Office of the Chief Scientist is uncertain and is subject to policy changes of the Israeli government, and that such grants may be insufficient to assist with product development; and other risks and uncertainties that may cause results to differ materially from those set forth in the forward-looking statements. The results of clinical trials in humans may produce results that differ significantly from the results of clinical and other trials in animals. The results of early-stage trials may differ significantly from the results of more developed, later-stage trials. The development of any products using the CTP platform technology could also be affected by a number of other factors, including unexpected safety, efficacy or manufacturing issues, additional time requirements for data analyses and decision making, the impact of pharmaceutical industry regulation, the impact of competitive products and pricing and the impact of patents and other proprietary rights held by competitors and other third parties.  In addition to the risk factors described above, investors should consider the economic, competitive, governmental, technological and other factors discussed in PROLOR's filings with the Securities and Exchang
'/>"/>
SOURCE PROLOR Biotech, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. GenWay Biotech Appoints New Vice President of Custom/OEM
2. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
3. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
4. Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis
5. TaiGen Biotechnology Out-Licensed China Rights of Novel Antibiotic, Nemonoxacin, to Zhejiang Medicine
6. Lifeline Biotechnologies, Inc. Receives Patent Award, a Device for Breast Tissue Temperature Analysis for Determining Cancer Conditions
7. Obamacare Ruling, Other Pivotal News Rocks Biotech Sector in June
8. Tougher Times May be Ahead for Biotechs: 1H12 Fundraising Slows
9. Last Chance to Save on Boston-Area Mobile Health, Biotech, and Pharmaceutical Conference Registration
10. Early Birds Save Up to $600 on Asian Biotech and Pharmaceutical Conferences
11. Lifeline Biotechnologies First Warning Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... CAESAREA, Israel , July 6, 2015 /PRNewswire/ ... enrollment of the first three patients in its ... study is a 184 patient randomized, single blinded ... balloon system to conventional repair or partial repair ... cuff tears.  While InSpace is currently commercially available ...
(Date:7/6/2015)... , July 6, 2015 Flower Orthopedics, ... concept the FlowerCube™, announced today that it has ... opportunity for significant expansion of the innovative FlowerCube™ ... The approval encompasses Flower Orthopedics, entire product line, ... upper and lower extremities. Consisting of more than ...
(Date:7/6/2015)... , July 6, 2015 ... initiatives to drive bioinformatics market in Germany ... a recently released TechSci Research report, " Germany Bioinformatics ... Germany is projected to register ... is expected to witness tremendous growth on account of ...
Breaking Medicine Technology:OrthoSpace Enrolls First Patients in US IDE Study 2Flower Orthopedics cleared to enter the European Union 2Germany Bioinformatics Market to Grow at a CAGR Over 29% Through 2020 Says TechSci Research 2Germany Bioinformatics Market to Grow at a CAGR Over 29% Through 2020 Says TechSci Research 3
(Date:7/7/2015)... ... 07, 2015 , ... Connexion Point is holding an onsite job fair to hire 400 people ... Place, Suite 100, this upcoming Wednesday, July 8, and Thursday, July 9, from 9:00 a.m. ... recruiting new applicants as well as holding onsite interviews. Interested parties are encouraged to ...
(Date:7/7/2015)... Chicago, Illinois (PRWEB) , ... July 07, 2015 ... ... in government program modernization, today announced they have been selected by the Department ... Validation (IV&V) services for its Medicaid Management Information System (MMIS) and Integrated Contact ...
(Date:7/6/2015)... ... July 06, 2015 , ... For over twenty years, Doctors on ... victims. Throughout the company’s history the goal has been to be a comprehensive ... their recovery. And while Doctors on Liens has certainly achieved that goal, the ...
(Date:7/6/2015)... ... July 06, 2015 , ... Human ... drug discovery. iPSCs are generated from adult cells, such as blood or skin, ... in the human body. , iPSC-derived cardiomyocytes have proven valuable ...
(Date:7/6/2015)... Laguna Woods, CA (PRWEB) , ... July 06, ... ... first Water Revival System that eliminates 100% of all acids, chemicals and impurities; ... not suggested for drinking water because it contains harmful contaminants.  These harmful contaminants ...
Breaking Medicine News(10 mins):Health News:Connexion Point, a tech enabled healthcare services company, is holding on-site job fair July 8th and 9th to fill 400 positions at its new Memphis location 2Health News:CSG Government Solutions Selected by the Department of Vermont Health Access to Provide Quality Assurance and Independent Verification and Validation Services 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 4Health News:Pristine Water Filters.com Offers The 1st Water Revival System That Re-Mineralizes Drinking Water and Eliminates All Impurities and Chemicals 2
... foods with oils containing alpha-linolenic acid may prevent arrhythmias, which ... studied 76,763 women who had completed a food questionnaire in ... Researchers then separated the women into five categories of ALA ... is found in a variety of leafy green vegetables, some ...
... are more likely to develop blood-related cancers when they ... hives are more likely to develop leukemia. Those who ... to develop non-Hodgkin’s lymphoma. ,Based on findings of ... to cancer because they stimulate the immune system to ...
... recent study suggest , eating fruits and vegetables won't ... ones risk for heart disease . ,For the ... exist between the foods and cancer and heart disease. ... two studies. They found total fruit and vegetable intake ...
... may be a strong link between Skin Allergies and cancer. People ... //to blood related caners as they grow older. A Swedish team ... issue of the BMC public Health. ,In this alarming ... more likely to develop Leukemia and those of us who ...
... transplantation has come a long way. The number of ... and more people lead a normal lifestyle. //However, a ... when matching donor and recipient kidneys,” gave not only ... transplant community. ,Researchers from the University ...
... young adults who have poor functioning of a key ... blockages in their arteries.// ,The researchers looked specifically ... blood vessels in the arteries, called endothelial functioning, affects ... 2,000 people were followed from childhood. Over the 21 ...
Cached Medicine News:
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: